HGT-20193-62058
2 vaccinations
2 coded responses
6 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 945 / CA
- Registered
- 2023-03-21
- Relationship
- Child or adolescent in my care
- Guardian
- VH3-18979-15693
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-12-02
Dose 1 — ModernaCo-administered: Flu:Other:Pneumonia:Rotavirus:Tetanus
-
2023-03-03
Dose 2 — Moderna
-
2023-03-21
Registered in v-safe
- 2023-03-21
-
2023-03-24
Survey response — 21 day, dose 2, under 3MedDRA: Cough, Nasopharyngitis, Patient isolation, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2023-03-31
- 2023-04-07
- 2023-04-14
-
2023-06-02
Survey response — 3 month, dose 2, under 3MedDRA: Influenza, Nasopharyngitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-12-02 | Moderna | Flu:Other:Pneumonia:Rotavirus:Tetanus |
| 2 | 2023-03-03 | Moderna | No |
Free text
None.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Patient isolation | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release